One of the reasons stem cell therapy holds much hope in the future of medicine is the fact that it is believed that in some years to come, it would be able to manufacture normal adult tissue to replace the damaged and old ones.
Use of embryonic stem cells remains debatable for several reasons. Among them are ethical issues that scientist haven’t been able to address properly. Among the successes of this project includes the use of autologous stem cells which are obtained directly from the patient.
Stem cells have proven to be quite useful in regenerative medicine. However, several scientists are still trying to figure out if it can work for cases related to soft tissue complications such as cartilage.
Autologous stem cells can be obtained from the bone marrow and fat from which after they are removed, they are concentrated. Some institutions go ahead and manufacture them outside the human body using several growth activators, and that is one of the reasons, they are having a hard time agreeing with the FDA.
Some centers have a lot of growth factors that don’t require processing these cells outside the body. They also don’t need to inject these cells into the location of the damage such as the joint. Instead, they’ll involve several procedures that combine the use of diagnostic ultrasound, magnetic resonance imaging and lastly, x-rays.
One of the reasons scientists advise the area of injury is that the original purpose of the Autologous stem cells incorporates inducing acute injury that is performed using several tools. These tools activate inflammation in the area that is affected.
Stem cells combined with growth factors are directly injected to the area affected, and the process of healing begins immediately.
If it is both the scientists and those who don’t like the procedure due to ethical issues can’t arrive at an agreement about the application of regenerative medicine which has been proven to treat damaged cartilage, then there is a high chance that the joint replacement therapy might take time.
Several issues haven’t been addressed. Here are some of them.
- Will autologous stem cells solve the problem?
- Must they be incubated outside the human body?
- Will the ASCs be able to survive the environment that they will be placed in/
- What more can it do to your body other than treating the targeted disease?
Unless the scientists can give those who oppose the procedure an answer, it will be hard for the world to allow them to continue with their research. One of the main issue here result from the fact that stem cells, unlike any other body cell, can multiply to form other body cells which make it a unique one, but also a risky one. However, scientists are doing what they can to find the answers that will inform the public of its importance.